trimethadione has been researched along with Chronic Kidney Failure in 1 studies
Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimethadione (TMO) was chosen as an indicator of quantitative hepatic microsomal function, and its pharmacokinetics were studied in 52 patients with chronic hepatitis." | 7.69 | Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity. ( Abei, M; Ikegami, T; Ishikawa, A; Matsuzaki, Y; Osuga, T; Tanaka, E; Tanaka, N, 1995) |
| "Trimethadione (TMO) was chosen as an indicator of quantitative hepatic microsomal function, and its pharmacokinetics were studied in 52 patients with chronic hepatitis." | 3.69 | Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity. ( Abei, M; Ikegami, T; Ishikawa, A; Matsuzaki, Y; Osuga, T; Tanaka, E; Tanaka, N, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abei, M | 1 |
| Tanaka, E | 1 |
| Tanaka, N | 1 |
| Matsuzaki, Y | 1 |
| Ikegami, T | 1 |
| Ishikawa, A | 1 |
| Osuga, T | 1 |
1 other study available for trimethadione and Chronic Kidney Failure
| Article | Year |
|---|---|
Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.
Topics: Chronic Disease; Dimethadione; Drug Tolerance; Female; Hepatitis; Hepatitis B; Hepatitis C; Hepatiti | 1995 |